| Item Type | Name |
|
Concept
|
Cisplatin
|
|
Academic Article
|
The impact of chemotherapy on the survival of patients with metastatic urothelial tumors.
|
|
Academic Article
|
Primary chemotherapy followed by a selective retroperitoneal lymphadenectomy in the management of clinical stage II testicular carcinoma: a preliminary report.
|
|
Academic Article
|
Testicular cancer in homosexual men with cellular immune deficiency: report of 2 cases.
|
|
Academic Article
|
Cisplatin, cyclophosphamide and doxorubicin chemotherapy for unresectable urothelial tumors: the M.D. Anderson experience.
|
|
Academic Article
|
Adjuvant cyclophosphamide, doxorubicin, and cisplatin chemotherapy for bladder cancer: an update.
|
|
Academic Article
|
Adjuvant chemotherapy of bladder cancer: a preliminary report.
|
|
Academic Article
|
Chemotherapy for adenocarcinomas of bladder and urachal origin: 5-fluorouracil, doxorubicin, and mitomycin-C.
|
|
Academic Article
|
Results of a phase II study with doxorubicin, etoposide, and cisplatin in patients with fully characterized small-cell carcinoma of the prostate.
|
|
Academic Article
|
Review of late complications of treatment and late relapse in testicular cancer.
|
|
Academic Article
|
Inhibition of RNA-dependent protein kinase (PKR) leads to cancer cell death and increases chemosensitivity.
|
|
Academic Article
|
Combination chemotherapy with methotrexate, bleomycin and cisplatin for advanced squamous cell carcinoma of the male genital tract.
|
|
Academic Article
|
A prospective randomized trial comparing MVAC and CISCA chemotherapy for patients with metastatic urothelial tumors.
|
|
Academic Article
|
Improved survival with cyclic chemotherapy for nonseminomatous germ cell tumors of the testis.
|
|
Academic Article
|
Cyclophosphamide, doxorubicin and cisplatin chemotherapy for patients with locally advanced urothelial tumors with or without nodal metastases.
|
|
Academic Article
|
Integrated therapy for locally advanced bladder cancer: final report of a randomized trial of cystectomy plus adjuvant M-VAC versus cystectomy with both preoperative and postoperative M-VAC.
|
|
Academic Article
|
A 20% dose reduction of the original CISCA/VB regimen allows better tolerance and similar survival rate in disseminated testicular non-seminomatous germ-cell tumors: final results of a phase III randomized trial.
|
|
Academic Article
|
Docetaxel in the management of advanced or metastatic urothelial tract cancer.
|
|
Academic Article
|
Treating refractory advanced or metastatic urothelial carcinoma with interleukin-2: a phase II study.
|
|
Academic Article
|
Treatment of chemotherapy-refractory metastatic urothelial tumors.
|
|
Academic Article
|
Intensive chemotherapy for metastatic nonseminomatous germ cell tumors.
|
|
Academic Article
|
Escalated therapy for refractory urothelial tumors: methotrexate-vinblastine-doxorubicin-cisplatin plus unglycosylated recombinant human granulocyte-macrophage colony-stimulating factor.
|
|
Academic Article
|
Preoperative chemotherapy in the treatment of germinal tumors.
|
|
Academic Article
|
Have aggressive chemotherapy regimens improved results in advanced germ cell tumors.
|
|
Academic Article
|
Interferon alternating with chemotherapy for patients with metastatic renal cell carcinoma.
|
|
Academic Article
|
Cyclophosphamide and sequential cisplatin for advanced seminoma: long-term followup in 52 patients.
|
|
Academic Article
|
Surgery in the management of stage III germinal cell tumors. Observations on the M.D. Anderson Hospital experience, 1971-1979.
|
|
Academic Article
|
Endodermal sinus tumor of the mediastinum. Report of apparent cure in two patients with extensive disease.
|
|
Academic Article
|
Chemotherapy of carcinoma of renal pelvis: preliminary report.
|
|
Academic Article
|
Escalated MVAC with or without recombinant human granulocyte-macrophage colony-stimulating factor for the initial treatment of advanced malignant urothelial tumors: results of a randomized trial.
|
|
Academic Article
|
Neoadjuvant cisplatin and interferon-alpha 2B in the treatment and organ preservation of penile carcinoma.
|
|
Academic Article
|
Alternating dose-dense chemotherapy in patients with high volume disseminated non-seminomatous germ cell tumours.
|
|
Academic Article
|
Treatment of refractory urothelial carcinoma with alternating paclitaxel, methotrexate, cisplatin (TMP) and 5-fluorouracil, alpha-interferon, cisplatin (FAP).
|
|
Academic Article
|
Cisplatin combination chemotherapy for elderly patients with urothelial tumours.
|
|
Academic Article
|
Cyclic chemotherapy with cyclophosphamide, doxorubicin, and cisplatin plus vinblastine and bleomycin in advanced germinal tumors. Results with 100 patients.
|
|
Academic Article
|
Chemotherapy of extragonadal germ cell tumors.
|
|
Academic Article
|
Complete responses in metastatic transitional cell carcinoma of the prostate with cisplatin regimens.
|
|
Academic Article
|
Paclitaxel, cisplatin and methotrexate combination chemotherapy is active in the treatment of refractory urothelial malignancies.
|
|
Academic Article
|
Pattern of failure and survival of patients with metastatic urothelial tumors relapsing after cis-platinum-based chemotherapy.
|
|
Academic Article
|
Cisplatin, gemcitabine, and ifosfamide as weekly therapy: a feasibility and phase II study of salvage treatment for advanced transitional-cell carcinoma.
|
|
Academic Article
|
Combined intravenous and intra-arterial cyclophosphamide, doxorubicin, and cisplatin (CISCA) in the management of select patients with invasive urothelial tumors.
|
|
Academic Article
|
Perioperative chemotherapy for the management of primary local regional urothelial tumors.
|
|
Academic Article
|
Optimal delivery of perioperative chemotherapy: preliminary results of a randomized, prospective, comparative trial of preoperative and postoperative chemotherapy for invasive bladder carcinoma.
|
|
Academic Article
|
Phase III trial of fluorouracil, interferon alpha-2b, and cisplatin versus methotrexate, vinblastine, doxorubicin, and cisplatin in metastatic or unresectable urothelial cancer.
|
|
Academic Article
|
Words of wisdom. Re: final results of sequential doxorubicin plus gemcitabine and ifosfamide, paclitaxel, and cisplatin chemotherapy in patients with metastatic or locally advanced transitional cell carcinoma of the urothelium.
|
|
Academic Article
|
A phase I study of FAP (5-Fluorouracil, a-interferon and cisplatin) combined with methotrexate for the treatment of advanced urothelial malignancies.
|
|
Academic Article
|
Personalised chemotherapy based on tumour marker decline in poor prognosis germ-cell tumours (GETUG 13): a phase 3, multicentre, randomised trial.
|
|
Academic Article
|
Sequential chemotherapy with cytoxan, adriamycin, and cis-platinum alternating with velban-bleomycin for stage III germinal cancer with poor prognosis
|
|
Academic Article
|
A phase I study of FAP (5-Fluorouracil, α-interferon and cisplatin) combined with methotrexate for the treatment of advanced urothelial malignancies
|
|
Academic Article
|
Integrative Clinical and Genomic Characterization of MTAP-deficient Metastatic Urothelial Cancer.
|
|
Academic Article
|
Comparative Effectiveness Analysis of Treatment Strategies for Surgically Resectable Neuroendocrine Carcinoma of the Urinary Tract.
|